Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 6:15:44 PM CDT


Stories related to: Zetia

Stories

3 Stories

  • April 2008
    • Firms Hid Bad News on Heart Drugs 2 Years: Doc

      Firms Hid Bad News on Heart Drugs 2 Years: Doc

      A scientist hired by two drug companies to conduct trials of cholesterol-lowering drugs accused the firms of deliberately delaying release of the results, the New York Times reports. The results for the Vytorin and Zetia trials—which showed the drugs don't work to reduce plaque in arteries—were not released until almost two years after the medical trials wrapped up.  More »

  • March 2008
  • January 2008
    • Generic Beats Pricey Pill on Cholesterol

      Generic Beats Pricey Pill on Cholesterol

      A cheap generic drug cuts arterial buildup as well as a pricey pill and may threaten the growth of two drug companies, Bloomberg reports. Vytorin is produced by Merck & Co. and Schering-Plough Corp. and costs $2.84 per dose; simvastin, a generic, costs 3 cents a pill and works just as well, according to a new study. Stocks fell for both companies after the news broke today. More »

      Tags

      heart attack   Merck   cholesterol   Schering Plough   Vytorin   LDL   Zetia

3 Stories

Today's Most Popular

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »